Home Careers Site Map Contact Us   ABOUT US About Sharon Vision/Mission Company History Board Members Our Values Regulatory Environmental Health & Safety RESEARCH & DEVELOPMENT FACILITIES Manufacturing API Facilities Formulations Toxicology Services SA-FORD PRODUCTS API's & Intermediates Formulations FINANCIALS Investor & Shareholders Quarterly Results Financial Highlights - 3yrs Reports Gallery Code of Conduct Corporate Governance Shareholding Patterns         Research & Development          OUR Facilities          SA-FORD          Events       SA-FORD, A division of Sharon Bio- Medicine Ltd. offers various toxicology services related to animals as per international...   Intermediate and API manufacturing Facility, Finished Dosage Facility etc.   SA-FORD stands for "Sanctuary for Research & Development" and is a newly established division.   The company adopts the business model for Contract Research and Manufacturing Services                         Our Brand         News/Stockmarket Registered it’s two brands in Kenya (Sharazole 40 – Paracetamol 40 mg. Tab & Plastum – Tamsulosin Caps), in Yemen have registered brand Ridosban – Hyosine Tabs. 10mg. & in Franco country Togo have registered Sharlum (Artemether + Lumefantrine )20/40/80 mg. Sharon have received approval from KFDA in month of March-12 for it’s API manufacturing plant L-6 Sharon have filed 4 US-DMF with USFDA In May-2011 Sharon have received first CEP for Product Trimetazidine Dihydrochloride

Home | Careers | Site Map | Contact Us follow us   About Us | Research & Development | Facilities | Products | Financials © 2011-2012 Sharon Bio-Medicine Ltd.     website designers mumbai